Next Six Months
Before Centinel acquired ProDisc family of products from DePuy Synthes there was a notable lack of information about ProDisc’s clinical experience in Europe and the U.S.
Now we know and, frankly, the data is impressive—125,000 implants; 400 published papers and 48 long-term follow-up papers. 13,000 patient results published in studies!
There’s also a need for updated papers.
When we checked for any published ProDisc-C Vivo or Nova studies, we could not find any—despite 21,500 implants combined. The only conference presentation we found was by Dr. Rudi Bertagnoli at ISASS 2013. At that meeting Dr. Bertagnoli presented ProDisc-C Nova outcomes for 179 patients (362 levels).
Over the course of the next six months we expect that Centinel Spine be working with numerous surgeons around the globe bring more of this data to journals for publishing and to podiums for presenting.
Next, we expect, will be a concerted effort to work on the lumbar disc arthroplasty issues—reimbursement, indications, etc.
Stay tuned, for sure.
